{"name":"Medivation, Inc.","slug":"medivation-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-05-01","label":"Dimebon Phase 3 readout (Alzheimer Type Dementia)","drug":"Dimebon","drugSlug":"dimebon","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dimebon","genericName":"Dimebon","slug":"dimebon","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Dimebon","genericName":"Dimebon","slug":"dimebon","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPT0F0RGFxa3hVUjh2cWhhZDBNelpCZVlzR21XSzdSV0lIcmxLcmhETGxNajNNRTZZNXo4UWw3MDlpQUw1RjJ0THNiTVNGYWp2MFlqZ2doZWpNZm1hZ1gtcFdaZGwwWFN5d2xSdFZUMnRlMlNscHE1M3VVN0RBcExOVkxOTjc1MnR0RnBadU5IWWNiLXo4WUN2ME01TnJEM1NiWXNORXQ0MTlIMS1mcGd5Y3duRzlBSWVyVTV0RWZKY0FITlU?oc=5","date":"2024-05-05","type":"pipeline","source":"UCLA Health","summary":"Astellas, Medivation to develop, commercialize MDV3100 for treatment of prostate cancer - UCLA Health","headline":"Astellas, Medivation to develop, commercialize MDV3100 for treatment of prostate cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPWGtvaDBIZGFUMS1UalVOT2N1MzUxbUpsdVNHTkFocEFWdlhxYnptX05GWXJSczhETmZZYkt2M25aSFlXaE5udGM3c2hWMXFjb2JXTEo2aHFaMUlEYUtIallHX05PdTZXZFlyVkxBZUVfWEdUQ3BLTW9hVFVGbzAtUXFCTC1UcnE0eFo3bkpjVDVtWmdVeFk2YTlqNFlSWUxBdU5tQ3hNb2RidUhTOHVsdEQ1Yl83dm10NGdhUUxUNmZuYWM?oc=5","date":"2021-08-17","type":"deal","source":"Fierce Pharma","summary":"5 years after Pfizer buyout, SEC charges Medivation's former deal-making lead with insider trading - Fierce Pharma","headline":"5 years after Pfizer buyout, SEC charges Medivation's former deal-making lead with insider trading","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQc0tGUThnMWlDUHM5bG5WN243QkJhc09ZZDUxOG0yZG9STzl3d0pNb2wyTF8ybkw1cUhqTmxISmpXM0lkR2JxeER2U3FRTVY5eEdidlo5RE52X1ZyekNOVnlBTWV4VG5SSU9kU3pJNVlwd1N1aXo4NkEzRjhqUk9mVlhMNkFlLXBreWc?oc=5","date":"2020-10-21","type":"pipeline","source":"BioPharma Dive","summary":"Ex-Medivation team nets $500M to take their new cancer drugmaker to Wall Street - BioPharma Dive","headline":"Ex-Medivation team nets $500M to take their new cancer drugmaker to Wall Street","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNVUk5TG5DUkVoSUtsbVFsME5qSjNGeXB6NDd5dllhd2JXQWRLdU1RaThGSWZTcW5HQ0t1S2RDT0JfRGNsZ1kwcjZuaEYzVGlKdUFoM3Fzak1LeVU3NnFJdVZBLUx5SzZUUzJvZUlNOEZ4N3dXNVExWGpQWURyVDF1QXZXdlp4eU9mcGFSTVFUeWJkMElBQnBZVA?oc=5","date":"2016-08-22","type":"pipeline","source":"Los Angeles Times","summary":"Pfizer to pay $14 billion for Medivation, whose drug Xtandi was discovered by UCLA - Los Angeles Times","headline":"Pfizer to pay $14 billion for Medivation, whose drug Xtandi was discovered by UCLA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBic3NCR044MmpsMUZ0RnpOVk9ZOUwxcTZfRlB4UkFtQkZ0dUhEWlM3MzEySmN2Nk91UzBaem5kemJwWmtXZWhoTHlqcnRaQVRUMHpQSHpHRF9wR0NmRVFFVWhtdmRHWVhkLU9QWkVUNUhySWl4eWladVpPYVRhQQ?oc=5","date":"2016-08-22","type":"deal","source":"statnews.com","summary":"Pfizer buying Medivation in deal valued at about $14 billion - statnews.com","headline":"Pfizer buying Medivation in deal valued at about $14 billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQTUpoWGJkSllBenFIQnlfdWUzYUVDdjJYV1VPRHNPMHhnZ1RfNFQtVDRGUlBjcTJvakRsbUo1Y29NWF9GWFF3QktYaHgwUS1nZ0NFYXFsbWdiVHdnRGZna0lQeEtFZ0FTZ1JVUlhQemFhc3ZPRWR2N1oxdEtmS08xRk90ZjloMFVTdzBVYWZGUWTSAZYBQVVfeXFMTVkwQW9GRmYyUGI4R2J5VmVQUWJoelRrRFNsS1dmdHN0VC1nS29SMThRNE45eVRNWjJXWUR2S21JVWdwd2YtUWk0SmJjb3dhNnNCTjFJTnJETzhXeWdNSU9XLUxzeWhsaDh1alFJR3hZX3A5V2hvOTBqQk9yd1M5eWoyYTNNTDNmQW14Q1NhanF5YVhOdE5n?oc=5","date":"2016-08-22","type":"deal","source":"CBS News","summary":"Pfizer buying cancer drug maker Medivation for $14B - CBS News","headline":"Pfizer buying cancer drug maker Medivation for $14B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQUVk4cFhrVmhwTmgydUpiM0ZVSEpyMnBPTFF2Tk10NDFEVThHQ0FnZWJLQVN6SHBnZ0FZSEczenF6N0swY1ZyMmRJVWlHcUtsbHpkbjBRQkEzWF9ySFZCMVdoVi1Eb0x2Ym9WOTI1aUFhVlZ3X1JnZXlINzJvZVRiRFBYU0ZyWHMxdGw5ei1VV2lnbnB5NGtLUVdWd0FuSlZTSDlMQlA3cGVLeFBvTTIyM0haNjA?oc=5","date":"2016-08-22","type":"pipeline","source":"Bloomberg.com","summary":"Pfizer Beats Out Sanofi to Take Medivation for $14 Billion - Bloomberg.com","headline":"Pfizer Beats Out Sanofi to Take Medivation for $14 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNa2NDVnlja1pDYUFFZW4yazBOV3ltaGRJbHV3UkwtVUItZTlWakpxUUkyZDdxd2dzcEp0SXNlT0Vwdy1WQ192UVdsY0RkbzFfRVNxbVJoellKc1hodF92eGJONzFodTJPTFBtWHZxOVRxS3NLNEdYT1ZSSndiSmg0d0RaUzQwUQ?oc=5","date":"2016-08-22","type":"deal","source":"WSJ","summary":"Pfizer to Buy Medivation for $14 Billion - WSJ","headline":"Pfizer to Buy Medivation for $14 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNNTlXeWhGX3hjcklFX2R5ZDJ4NmFkSktSR1FBcWQ0RWtoSkxvMEdFSWJSUm1rWmlCamRicTdIaUNlR3l4aVprS3BORlpLNk90MDdEdzBpRExWTFdtcll6OXZ2QVpKTnM2dzNkeDRpUXI5M2MtbUtQY2VxQTI3SWthWVNUOC1iTXYxQklDNnFiWnhwZ2JxcWdOT0YtUFgyYTN0bDRNTjF3TVk0SzJLenlacmQxcFYzeUVoTXFQejFR?oc=5","date":"2016-05-10","type":"pipeline","source":"Reuters","summary":"Exclusive: Medivation succumbs to pressure to explore sale - sources - Reuters","headline":"Exclusive: Medivation succumbs to pressure to explore sale - sources","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPUU1CSFVpRFNuenU2cGV4YmpKb0hyRUJRQUZWNC12T1hvYW9uUWc1ZTBwU2VWQTNacXJveUVPdDcta0ljQWdOM09IbENRYVBoMWJrblcxTEYyeFAtOWJ5Ujk2ZGVSSXZlWkE2T3czaHBjLU9yeDFRZFgxLTJrWGhBbi1kV1JDLVBBY2dnLTBaMnFyT28?oc=5","date":"2016-03-29","type":"pipeline","source":"The Seattle Times","summary":"Pricey prostate cancer drug’s makers targeted by Congress - The Seattle Times","headline":"Pricey prostate cancer drug’s makers targeted by Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxONFRZS2pmU0NReWJzTkQ0dUhpVjc5U0pBb3g0N1lxUHVqV19rWjFSRkJmSXNpV1AyTGlZRHRXOTVDalB6TVFObExuWk9BUGpOMVpzTnJOT3hNWkEyUGtHeXN1M09rbG9leFVwVXZ1TkotTVB6dnVQWE43TVFJUGxjaUpjX0hhVmfSAYwBQVVfeXFMUERxLXRXVkZSM0FoVGNmc0VaWU8yNjYtVlRyXy1TaUxMTlZrZWktaTBLOUF0OENzb0s1TlpwdzlRWDBXZEkzV0NIXzNFdG1iWkxPVFNQMGxJQ3BVRVc2YmotaEJPM2NFRzZfRk0tdThRNVIwMFREVWdITGNvTWlxRklWNGlJWS1SRk04V0c?oc=5","date":"2015-01-08","type":"pipeline","source":"Fox Business","summary":"Why Medivation Inc. Stock Sank 14% in December - Fox Business","headline":"Why Medivation Inc. Stock Sank 14% in December","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQMzU2MGp6eV9DTEdvNUZKWnFWTnBWT0k4OV9ZdkZLN2dPWVZ3d0pQUFhZYjlaMUNvUFVSd29peUtGdEU0SFo1SzZ1aUhMd0xjankzUVB4WEZOZnRrMTh3NkJrMVpORVR3UG4wTVpPOU12Mk9lOEdhTW55aHVfZHJyRWd6VWhLSjZFeTNEcWVlekxNa0pfMWhjQ3NNTWxraEFwajRiYVNKXzdkNVBzaExaemtTSnJqc19sZXJUbEZ1Zw?oc=5","date":"2014-09-10","type":"pipeline","source":"multivu.com","summary":"(enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer - multivu.com","headline":"(enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}